PAVmed (PAVM) Amortization of Deferred Charges (2017 - 2018)

PAVmed (PAVM) posted quarterly Amortization of Deferred Charges of $505848.0 for Q3 2018, up 65.45% quarter-over-quarter from $305734.0 in Q2 2018.

PAVmed (PAVM) Amortization of Deferred Charges (2017 - 2018) Analysis & Trends

PAVmed's Amortization of Deferred Charges history runs 2 years deep, the most recent figure standing at $505848.0 for Q3 2018.

In Q3 2018, Amortization of Deferred Charges changed N/A year-over-year to $505848.0; the TTM figure through Sep 2018 stood at $1.3 million (changed N/A YoY), while the FY2017 annual figure was $347601.0, changed N/A from the prior year.
Amortization of Deferred Charges for Q3 2018 stood at $505848.0, up from $305734.0 in the prior quarter.
The five-year high for Amortization of Deferred Charges was $505848.0 in Q3 2018, with the low at $172959.0 in Q4 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn
10	PAVmed	32.48 Mn	28.69 Mn	-89,000.00

Download Data